{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:24:39Z","timestamp":1781108679992,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejso.2023.03.230","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T18:35:43Z","timestamp":1680201343000},"page":"1495-1503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-9172","authenticated-orcid":false,"given":"Felipe","family":"Lopez-Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-9489","authenticated-orcid":false,"given":"Armando","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Studeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-3827","authenticated-orcid":false,"given":"Mary Caitlin","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-1416","authenticated-orcid":false,"given":"Luis Felipe","family":"Falla-Zuniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-5477","authenticated-orcid":false,"given":"Andrei","family":"Nikiforchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-6547","authenticated-orcid":false,"given":"Ekaterina","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-5660","authenticated-orcid":false,"given":"Vadim","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0881-3236","authenticated-orcid":false,"given":"Teresa","family":"Diaz-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2023.03.230_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2011.12.418","article-title":"Carcinosarcoma of the ovary: a review of the literature","volume":"125","author":"Del Carmen","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.03.230_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.ejso.2023.03.230_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0090-8258(84)90039-8","article-title":"A\u00a0clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: a gynecologic oncology group study","volume":"18","author":"Morrow","year":"1984","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2023.03.230_bib4","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/IGC.0000000000000228","article-title":"Gynecologic cancer intergroup (GCIG) consensus review for uterine and ovarian carcinosarcoma","volume":"24","author":"Berton-Rigaud","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2023.03.230_bib5","series-title":"Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: a National Cancer Database analysis","author":"Rauh-Hain","year":"2016"},{"issue":"3","key":"10.1016\/j.ejso.2023.03.230_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2011.02.023","article-title":"Carcinosarcoma of the ovary: a case-control study","volume":"121","author":"Rauh-Hain","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2023.03.230_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2005.07.119","article-title":"Carcinosarcoma of the ovary - a case series","volume":"100","author":"Rutledge","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2023.03.230_bib8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/1097-0142(19951001)76:7<1209::AID-CNCR2820760717>3.0.CO;2-V","article-title":"Malignant mixed m\u00fcllerian tumors of the ovary. Experience with surgical cytoreduction and combination chemotherapy","volume":"76","author":"Muntz","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2023.03.230_bib9","first-page":"2148","article-title":"Carcinosarcoma of the ovary","volume":"100","author":"Ewan","year":"2004","journal-title":"Cancer"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2023.03.230_bib10","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.5500","article-title":"A\u00a0randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: an NRG Oncology trial","volume":"37","author":"Powell","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2023.03.230_bib11","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2014.55.9898","article-title":"Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study","volume":"33","author":"Tewari","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.03.230_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"Van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ejso.2023.03.230_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/1754-9493-6-12","article-title":"Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients","volume":"6","author":"Warschkow","year":"2012","journal-title":"Patient Saf Surg"},{"issue":"11","key":"10.1016\/j.ejso.2023.03.230_bib14","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.ejso.2017.08.011","article-title":"Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"43","author":"Sardi","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2023.03.230_bib15","series-title":"World Health organization classification of tumours of the female reproductive organs","author":"Kurman","year":"2014"},{"issue":"2","key":"10.1016\/j.ejso.2023.03.230_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3802\/jgo.2015.26.2.87","article-title":"FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication","volume":"26","author":"Prat","year":"2015","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2023.03.230_bib17","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.hoc.2012.08.010","article-title":"Neoplasms of the appendix: current treatment guidelines","volume":"26","author":"Shankar","year":"2012","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.ejso.2023.03.230_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.ejso.2023.03.230_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.03.230_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2023.03.230_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4082-6","article-title":"Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature","volume":"18","author":"Brackmann","year":"2018","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2023.03.230_bib22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41416-022-01874-8","article-title":"Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma","volume":"127","author":"Hollis","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2023.03.230_bib23","series-title":"The role of tumor tissue architecture in treatment penetration and efficacy: an integrative study","author":"Rejniak","year":"2013"},{"issue":"1","key":"10.1016\/j.ejso.2023.03.230_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/pp-2018-0101","article-title":"The concept of \u201cobstruction-Free Survival\u201d as an outcome measure in advanced colorectal cancer management","volume":"3","author":"Moran","year":"2018","journal-title":"Pleura and Peritoneum"},{"issue":"2","key":"10.1016\/j.ejso.2023.03.230_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0090-8258(81)90148-7","article-title":"The management of ovarian-cancer-caused bowel obstruction","volume":"12","author":"Tunca","year":"1981","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2023.03.230_bib26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0046-8177(88)80281-8","article-title":"Survival time, causes of death, and tumor\/treatment-related morbidity in 100 women with ovarian cancer","volume":"19","author":"Dvoretsky","year":"1988","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2023.03.230_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10147-017-1215-x","article-title":"Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment","volume":"23","author":"Yalcin","year":"2018","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.03.230_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics9040200","article-title":"Overall survival and adjuvant therapy in women with ovarian carcinosarcoma: a single-institution experience","volume":"9","author":"Nizam","year":"2019","journal-title":"Diagnostics"},{"issue":"20","key":"10.1016\/j.ejso.2023.03.230_bib29","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2023.03.230_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(21)00006-1","article-title":"Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Shi","year":"2021","journal-title":"Lancet Oncol"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2023.03.230_bib31","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.6000","article-title":"Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: final analysis of AGO DESKTOP III\/ENGOT-ov20","volume":"38","author":"Du Bois","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2023.03.230_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2013.06.034","article-title":"Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome","volume":"131","author":"George","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.03.230_bib33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ygyno.2007.01.037","article-title":"Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience","volume":"105","author":"Leiser","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.03.230_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/gyno.2002.6645","article-title":"Paclitaxel and platinum chemotherapy for malignant mixed mullerian tumors of the ovary","volume":"85","author":"Duska","year":"2002","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323004304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323004304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:48:42Z","timestamp":1760060922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323004304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0748798323004304"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.03.230","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.03.230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}